Insights / Events
Keep up with Primrose Bio’s
latest events
Primrose Bio at BIO International Convention 2025
Primrose Bio joined BIO 2025 in Boston to showcase innovations in RNA polymerase, protein expression, and CRM197 carrier protein for next-gen therapeutics.
Primrose Bio Presents at Oxford Nanopore Biopharma Day
On June 12, 2025, Tyler Dang, PhD represented Primrose Bio at Oxford Nanopore Technologies’ inaugural Biopharma Day in San Diego. This regional event brought together...
Primrose Bio Highlights High-Throughput Enzyme Screening at Cytiva’s Process Development Virtual Summit
At Cytiva’s Process Development Summit, Primrose Bio showcased a high-throughput enzyme screening method using Protein Select™ and Pfenex Expression Technology®.
Primrose Bio Presents Enzymatic Innovation at TIDES USA 2025
Primrose Bio joined TIDES USA 2025 in San Diego to present enzymatic solutions for nucleic acid manufacturing, including new innovations in RNA polymerase design.
Primrose Bio Presents Pfast™ at Antibody Engineering & Therapeutics Spring Digital Week
On May 21, 2025, Primrose Bio participated in the Antibody Engineering & Therapeutics Spring Digital Week, a virtual event hosted in collaboration with The Antibody Society. Russell Coleman delivered a featured presentation titled “Pfast™ Protein Expression: A Rapid, Robust Solution,” highlighting the capabilities of our P. fluorescens–based Pfenex Expression Technology®.
Primrose Bio Showcases Pfenex Platform and Pfast™ at PEGS US 2025
Primrose Bio highlighted Pfast™ and Pfenex Expression Technology® at PEGS Boston 2025, advancing complex protein development and biotherapeutic screening.
3rd Annual mRNA Process Development & Manufacturing Summit
Primrose Bio presented key mRNA manufacturing advancements at the 2025 Berlin Summit, including talks on polymerase selection and RNA synthesis innovation.
Primrose Bio at World Vaccine Congress 2025: Showcasing Innovation in mRNA Manufacturing
Primrose Bio was proud to exhibit and present at the World Vaccine Congress 2025, held April 22–25 in Washington, D.C. Our team shared insights into next-generation solutions for biotherapeutics and vaccine manufacturing, highlighting our Prima RNApols™ platform for high-quality, streamlined, and cost-effective mRNA synthesis.
Primrose Bio Heads to Bio-Europe Spring 2025
Primrose Bio was proud to participate in Bio-Europe Spring 2025, held March 17–19 in Italy. Representing the team, Alec Tzianabos connected with global partners to discuss our scalable, efficient, and cost-effective manufacturing solutions for complex biologics. The event provided a valuable forum to share insights and explore collaborations that advance innovation in drug development and design.
JPM 2025: Advancing Biotech Collaboration
Primrose Bio kicked off the year at JPM Week 2025 in San Francisco, where our executive team — Helge Zieler (CEO), Simon Latimer (CFO), Michele Rubino (CBO), and Louis J. Cantolupo (VP of Business Development) — met with partners, investors, and biotech innovators. We had productive conversations focused on solving complex challenges in drug design and manufacturing. It was an energizing start to the year, filled with opportunities for meaningful collaboration and growth.
